Description
THE PURPOSE OF THIS MODIFICATION IS TO DECREASE VA255-P-1791 - VA255-15-J-1407 - 589C52183 BY $72,206.00. THE TOTAL AMOUNT IS CHANGED FROM $133,800.00 TO $61,594.00. THE TOPEKA AND LEAVENWORTH VAMCS USED FEWER AMOUNTS THAN THE ANTICIPATED QUANTITIES LISTED ON THE CONTRACT. THE PERIOD OF PERFORMANCE (POP) WAS 4/1/2015 - 3/31/2016. ALL INVOICES HAVE BEEN SUBMITTED AND PAID.
Base award description: EASTERN KANSAS RADIOPHARMACEUTICALS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-02-19+$133,800= $133,800
- Mod P000012016-12-21-$72,206= $61,594
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-02-19 | +$133,800 | $133,800 | EASTERN KANSAS RADIOPHARMACEUTICALS |
| Mod P00001· FUNDING ONLY ACTION | 2016-12-21 | −$72,206 | $61,594 | THE PURPOSE OF THIS MODIFICATION IS TO DECREASE VA255-P-1791 - VA255-15-J-1407 - 589C52183 BY $72,206.00. THE… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NSF1TBMFUU36)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA25514J1920 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $110,289 | FY2014 |
| VA25513J1268 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $150,307 | FY2013 |
| VA25513J0113 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $59,565 | FY2013 |
| VA25512J0344 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $127,400 | FY2012 |
| VA255589EC1665 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $69,546 | FY2011 |
| VA255P1791 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2011 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526N0376 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $233,435 | FY2026 |
| 36C25526N0394 | NOVARTIS PHARMACEUTICALS CORPORATION | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $891,651 | FY2026 |
| 36C25526N0392 | SOFIE CO. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $357,066 | FY2026 |
| 36C25526N0361 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $228,679 | FY2026 |
| 36C25526D0057 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25515J1407_3600_VA255P1791_3600 · retrieved 2026-09-26.